DCF — KARMANOS CANCER HOSPITAL
Enterprise Value: $-251.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-251.9M
Enterprise Value
$-84.2M
PV of Cash Flows
$-167.6M
PV of Terminal Value
$-269.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $293.3M | $-13.2M | -5.0% | $-25.6M | $-23.3M |
| Year 2 | $302.1M | $-10.6M | -4.0% | $-23.4M | $-19.3M |
| Year 3 | $311.2M | $-7.8M | -3.0% | $-21.0M | $-15.7M |
| Year 4 | $320.5M | $-6.4M | -2.0% | $-20.0M | $-13.6M |
| Year 5 | $330.1M | $-5.8M | -2.0% | $-19.8M | $-12.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-251.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$284.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000087788477
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5